mamedica limited
mamedica limited Company Information
Company Number
13570731
Next Accounts
May 2026
Directors
Shareholders
mamedica group limited
Group Structure
View All
Industry
Other human health activities
Registered Address
rothamstead research, west common, harpenden, AL5 2JQ
Website
-mamedica limited Estimated Valuation
Pomanda estimates the enterprise value of MAMEDICA LIMITED at £1.2m based on a Turnover of £2.6m and 0.45x industry multiple (adjusted for size and gross margin).
mamedica limited Estimated Valuation
Pomanda estimates the enterprise value of MAMEDICA LIMITED at £0 based on an EBITDA of £-1.1m and a 3.35x industry multiple (adjusted for size and gross margin).
mamedica limited Estimated Valuation
Pomanda estimates the enterprise value of MAMEDICA LIMITED at £0 based on Net Assets of £-1.9m and 2.46x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Mamedica Limited Overview
Mamedica Limited is a live company located in harpenden, AL5 2JQ with a Companies House number of 13570731. It operates in the other human health activities sector, SIC Code 86900. Founded in August 2021, it's largest shareholder is mamedica group limited with a 100% stake. Mamedica Limited is a startup, small sized company, Pomanda has estimated its turnover at £2.6m with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Mamedica Limited Health Check
Pomanda's financial health check has awarded Mamedica Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
1 Regular
3 Weak
Size
annual sales of £2.6m, make it larger than the average company (£750.6k)
- Mamedica Limited
£750.6k - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Mamedica Limited
- - Industry AVG
Production
with a gross margin of 22.7%, this company has a higher cost of product (38.3%)
- Mamedica Limited
38.3% - Industry AVG
Profitability
an operating margin of -40.7% make it less profitable than the average company (5.4%)
- Mamedica Limited
5.4% - Industry AVG
Employees
with 25 employees, this is above the industry average (19)
25 - Mamedica Limited
19 - Industry AVG
Pay Structure
on an average salary of £27.6k, the company has an equivalent pay structure (£27.6k)
- Mamedica Limited
£27.6k - Industry AVG
Efficiency
resulting in sales per employee of £104.8k, this is more efficient (£48.3k)
- Mamedica Limited
£48.3k - Industry AVG
Debtor Days
it gets paid by customers after 14 days, this is earlier than average (19 days)
- Mamedica Limited
19 days - Industry AVG
Creditor Days
its suppliers are paid after 367 days, this is slower than average (16 days)
- Mamedica Limited
16 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Mamedica Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Mamedica Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 1897.3%, this is a higher level of debt than the average (24.1%)
1897.3% - Mamedica Limited
24.1% - Industry AVG
MAMEDICA LIMITED financials
Mamedica Limited's latest turnover from August 2024 is estimated at £2.6 million and the company has net assets of -£1.9 million. According to their latest financial statements, Mamedica Limited has 25 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Aug 2024 | Aug 2023 | Aug 2022 | |
|---|---|---|---|
| Turnover | |||
| Other Income Or Grants | |||
| Cost Of Sales | |||
| Gross Profit | |||
| Admin Expenses | |||
| Operating Profit | |||
| Interest Payable | |||
| Interest Receivable | |||
| Pre-Tax Profit | |||
| Tax | |||
| Profit After Tax | |||
| Dividends Paid | |||
| Retained Profit | |||
| Employee Costs | |||
| Number Of Employees | 25 | 7 | 2 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Aug 2024 | Aug 2023 | Aug 2022 | |
|---|---|---|---|
| Tangible Assets | 489 | 642 | 972 |
| Intangible Assets | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 |
| Total Fixed Assets | 489 | 642 | 972 |
| Stock & work in progress | 0 | 0 | 0 |
| Trade Debtors | 107,076 | 3,566 | 23,428 |
| Group Debtors | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 |
| Cash | 0 | 0 | 0 |
| misc current assets | 0 | 0 | 0 |
| total current assets | 107,076 | 3,566 | 23,428 |
| total assets | 107,565 | 4,208 | 24,400 |
| Bank overdraft | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 |
| Trade Creditors | 2,040,850 | 870,096 | 247,475 |
| Group/Directors Accounts | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 |
| total current liabilities | 2,040,850 | 870,096 | 247,475 |
| loans | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 |
| total liabilities | 2,040,850 | 870,096 | 247,475 |
| net assets | -1,933,285 | -865,888 | -223,075 |
| total shareholders funds | -1,933,285 | -865,888 | -223,075 |
| Aug 2024 | Aug 2023 | Aug 2022 | |
|---|---|---|---|
| Operating Activities | |||
| Operating Profit | |||
| Depreciation | |||
| Amortisation | |||
| Tax | |||
| Stock | 0 | 0 | 0 |
| Debtors | 103,510 | -19,862 | 23,428 |
| Creditors | 1,170,754 | 622,621 | 247,475 |
| Accruals and Deferred Income | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 |
| Cash flow from operations | |||
| Investing Activities | |||
| capital expenditure | |||
| Change in Investments | 0 | 0 | 0 |
| cash flow from investments | |||
| Financing Activities | |||
| Bank loans | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 |
| share issue | |||
| interest | |||
| cash flow from financing | |||
| cash and cash equivalents | |||
| cash | 0 | 0 | 0 |
| overdraft | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 |
mamedica limited Credit Report and Business Information
Mamedica Limited Competitor Analysis
Perform a competitor analysis for mamedica limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in AL5 area or any other competitors across 12 key performance metrics.
mamedica limited Ownership
MAMEDICA LIMITED group structure
Mamedica Limited has no subsidiary companies.
Ultimate parent company
MAMEDICA LIMITED
13570731
mamedica limited directors
Mamedica Limited currently has 1 director, Mr Jonathan Robson serving since Aug 2021.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Jonathan Robson | England | 38 years | Aug 2021 | - | Director |
P&L
August 2024turnover
2.6m
+205%
operating profit
-1.1m
0%
gross margin
22.8%
+5.02%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2024net assets
-1.9m
+1.23%
total assets
107.6k
+24.56%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
mamedica limited company details
company number
13570731
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
August 2021
age
4
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
August 2024
previous names
delta 9 clinics limited (October 2021)
accountant
-
auditor
-
address
rothamstead research, west common, harpenden, AL5 2JQ
Bank
-
Legal Advisor
-
mamedica limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to mamedica limited.
mamedica limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MAMEDICA LIMITED. This can take several minutes, an email will notify you when this has completed.
mamedica limited Companies House Filings - See Documents
| date | description | view/download |
|---|
